Tango Therapeutics, Inc.

TNGX · Nasdaq · SIC 2834: Pharmaceutical Preparations
73
SEC Filings

Business Summary

7 Item 1A. Risk Factors 36 Item 1B. Unresolved Staff Comments 83 Item 1C Cybersecurity 83 Item 2. Properties 84 Item 3. Legal Proceedings 84 Item 4. Mine Safety Disclosures 84 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 85 Item 6. [Reserved] 86 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 87 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 97 Item 8. ...

Next Earnings

Q2 FY2026 — expected 2026-08-11

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionTNGXdiscussed_in_filing Cybersecurity
topic_mentionTNGXdiscussed_in_filing Cybersecurity
topic_mentionTNGXdiscussed_in_filing Cybersecurity
topic_mentionTNGXdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-052025-12-310001193125-26-092518EDGAR97K words
2025-02-272024-12-310000950170-25-028353EDGAR—
2024-03-182023-12-310000950170-24-032516EDGAR—
2023-03-272022-12-310000950170-23-009854EDGAR—
2022-03-282021-12-310000950170-22-004721EDGAR—
2021-03-312020-12-310001213900-21-019249EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-042025-09-300001193125-25-263680EDGAR29K words
2025-08-052025-06-300000950170-25-102392EDGAR—
2025-05-122025-03-310000950170-25-068549EDGAR—
2024-11-062024-09-300000950170-24-121818EDGAR—
2024-08-072024-06-300000950170-24-092274EDGAR—
2024-05-082024-03-310000950170-24-055065EDGAR—
2023-11-082023-09-300000950170-23-060682EDGAR—
2023-08-072023-06-300000950170-23-038750EDGAR—
2023-05-092023-03-310000950170-23-019140EDGAR—
2022-11-102022-09-300000950170-22-024219EDGAR—
2022-08-102022-06-300000950170-22-016257EDGAR—
2022-05-112022-03-310000950170-22-009139EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-050001193125-26-092535EDGAR3K words
2026-01-080001193125-26-007086EDGAR—
2026-01-050001193125-26-001495EDGAR—
2025-11-210001193125-25-290679EDGAR—
2025-11-040001193125-25-263684EDGAR—
2025-10-240001193125-25-249302EDGAR—
2025-10-230001193125-25-247658EDGAR—
2025-08-250001193125-25-187680EDGAR—
2025-08-050000950170-25-102387EDGAR—
2025-06-060001193125-25-137032EDGAR—

73 total filings indexed. 45 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001819133
TickerTNGX
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 6c63ecec66f430bde6b1a6c6caa14b2e4d5eb3ab7698e6c963723665347945f0
parent: cda857d1c35d4609437bb0655b08a5f7c8c0ecc3b7bf6f70775f2977b246d2e4
content hash: 01fbd1bd9ec2e48d6ea1cf9761991149c96f9a5ec9b7b4778fbe2f1c3f313049
signed: 2026-04-13T04:47:50.294Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf